IRIS
CORRADO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.876
NA - Nord America 6.762
AS - Asia 3.576
SA - Sud America 1.121
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 103
OC - Oceania 12
Totale 19.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.584
RU - Federazione Russa 4.043
SG - Singapore 1.508
CN - Cina 1.129
BR - Brasile 948
IE - Irlanda 879
SE - Svezia 823
DE - Germania 408
IT - Italia 389
HK - Hong Kong 348
UA - Ucraina 289
FR - Francia 284
PL - Polonia 212
VN - Vietnam 192
GB - Regno Unito 187
FI - Finlandia 181
IN - India 103
CA - Canada 81
AR - Argentina 65
BD - Bangladesh 52
MX - Messico 47
BE - Belgio 46
JP - Giappone 31
TR - Turchia 31
ZA - Sudafrica 30
NL - Olanda 29
IQ - Iraq 27
EC - Ecuador 25
ES - Italia 25
MA - Marocco 25
PK - Pakistan 22
ID - Indonesia 18
VE - Venezuela 18
UZ - Uzbekistan 17
AT - Austria 16
CO - Colombia 16
CZ - Repubblica Ceca 13
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
SA - Arabia Saudita 11
AU - Australia 10
AZ - Azerbaigian 10
PE - Perù 10
PH - Filippine 10
AL - Albania 9
KE - Kenya 9
CL - Cile 8
JM - Giamaica 8
PY - Paraguay 8
RO - Romania 8
TN - Tunisia 8
EG - Egitto 7
IR - Iran 7
JO - Giordania 7
KZ - Kazakistan 7
BO - Bolivia 6
CI - Costa d'Avorio 6
HN - Honduras 6
LT - Lituania 6
MY - Malesia 6
BB - Barbados 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
GY - Guiana 5
NI - Nicaragua 5
KR - Corea 4
LU - Lussemburgo 4
NP - Nepal 4
RS - Serbia 4
DZ - Algeria 3
GE - Georgia 3
IL - Israele 3
KH - Cambogia 3
LV - Lettonia 3
NG - Nigeria 3
PT - Portogallo 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
CH - Svizzera 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
Totale 19.438
Salva come PNG Salva come JPEG
Città #
Ashburn 1.110
Moscow 1.065
Singapore 892
Dublin 878
Chandler 643
Jacksonville 576
Dallas 537
Nyköping 431
Beijing 400
San Jose 373
Hong Kong 348
Warsaw 193
Council Bluffs 183
Boardman 160
Ann Arbor 157
Los Angeles 157
The Dalles 157
Lauterbourg 131
Princeton 129
Cambridge 127
Messina 120
Munich 111
Medford 110
Dearborn 106
Des Moines 101
São Paulo 81
Ho Chi Minh City 68
Buffalo 64
Santa Clara 61
Woodbridge 61
New York 59
Brussels 46
Shenyang 40
Tianjin 40
Jinan 39
Catania 38
Frankfurt am Main 37
Turku 37
Wilmington 36
Bremen 35
Hanoi 34
Columbus 33
Guangzhou 31
Hyderabad 29
Orem 28
Montreal 27
Tokyo 27
Belo Horizonte 26
Düsseldorf 26
Houston 26
Denver 25
Hebei 25
Lancaster 25
London 25
Nanjing 25
Chennai 24
Redondo Beach 24
Zhengzhou 24
Brooklyn 23
Helsinki 23
Rio de Janeiro 23
Seattle 23
Washington 23
Atlanta 22
San Mateo 21
Phoenix 19
Shanghai 19
Stockholm 19
Amsterdam 17
Curitiba 17
Porto Alegre 17
Boston 16
Johannesburg 16
Hangzhou 15
Ningbo 15
San Francisco 15
Brasília 14
Chicago 14
Haikou 14
Manchester 14
Tashkent 14
Mexico City 13
Ottawa 13
Sorocaba 13
Auburn Hills 12
Baghdad 12
Dong Ket 12
Milan 12
Taizhou 12
Da Nang 11
Mumbai 11
Pune 11
Rome 11
Shenzhen 11
Toronto 11
Quito 10
Wroclaw 10
Baku 9
Campinas 9
Guayaquil 9
Totale 11.046
Salva come PNG Salva come JPEG
Nome #
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 253
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 244
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 241
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 231
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 224
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 220
Italian risk factor-based screening for gestational diabetes. 211
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 210
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 209
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 208
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 207
A 45,MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y EUCHROMATIN ONTO CHROMOSOME 1 205
Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis 205
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 203
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 202
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 200
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 199
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 196
Myo-inositol may prevent gestational diabetes in PCOS women 195
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 194
A 45,X MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y- EUCHROMATIN ONTO CHROMOSOME-1 191
Abortività spontanea ed età materna avanzata. 188
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 187
C-reactive protein as an early predictor of gestational diabetes mellitus 186
Cardiovascular effects of raloxifene hydrochloride 186
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 184
Effects of myo-inositol on glucose variability in women with gestational diabetes 184
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 181
Screening for gestational diabetes in Sicily. 179
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 179
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 176
Intravaginal vs. intracervical PGE(2) gel first application for labor induction 174
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 174
"Anticorpi antifosfolipidi ed aborto ricorrente". 172
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 172
Glucose Tolerance and insulin secretion in pregnancy 171
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 171
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 171
Cardiovascular effects of the phytoestrogen genistein 170
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 170
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 169
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 169
Celiac disease in pregnancy: not always a relapse 168
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 167
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 166
PREGNANCY IN ESSENTIAL THROMBOCYTHEMIA DURING ASPIRIN TREATMENT 165
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 165
Compliance with hormone replacement therapy in postmenopausal Sicilian women 164
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 164
A randomised trial of progesterone prophylaxis after midtrimester amniocentesis 162
Maternal serum PAPP-A as an early marker of obstetric complications? 162
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 162
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 161
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 161
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 160
First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia 159
Effects of a phyto complex on well-being of climacteric women 159
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 158
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 156
Midtrimester amniotic fluid adiponectin in normal pregnancy. 153
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 153
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 152
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 151
Differences in body composition between post-menopausal women with and without dyslipidemia. 151
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 150
Diagnosis of gestational diabetes mellitus: italian perspectives on risk factor based screening 149
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 148
Pregnancy outcome following mid-trimester amniocentesis 144
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 142
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 141
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 141
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 141
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 141
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 140
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 139
Screening for gestational diabetes in Sicily 138
La disfunzione diastolica nel diabete gestazionale 138
Diagnosis of celiac disease in pregnancy and puerperium: think about it 137
Modalità di prelievo in corso d'amniocentesi ed outcome ostetrico 137
A 45,X male with molecular evidence of a translocation of Y euchromatin onto chromosome 1 136
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 136
Sindrome mano-piede-utero. Descrizione di un caso ad ereditarietà autosomica recessiva. 133
Spontaneous abortion and advanced maternal age 133
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 132
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 131
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 131
Hand-foot-uterus syndrome: a report of a case with recessive autosomal inhereditance 131
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 131
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 129
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 127
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 127
Intolleranza glucidica e disordini ipertensivi in gravidanza. 126
TESTICULAR REGRESSION SYNDROME - A CASE-REPORT 124
Role of urocortin in pregnancy: an update and future perspectives 123
Predittività dell’OGTT sugli outcomes clinici ed ostetrici nella ridotta tolleranza glucidica in gravidanza 120
La disfunzione diastolica nel diabete gestazionale 119
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 118
Safe introduction of ancillary trocars in gynecological surgery: the "yellow island" anatomical landmark 118
Inflammatory markers in women with a recent history of gestational diabetes mellitus 115
Prenatally identified Pallister-Killian syndrome: Ultrasound pattern and diagnostic considerations 114
Totale 16.460
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022813 0 0 18 28 35 11 60 37 24 239 105 256
2022/20232.621 181 260 140 171 218 263 15 155 1.094 15 82 27
2023/2024703 54 96 46 97 64 113 16 21 7 46 7 136
2024/20252.796 44 34 52 196 127 114 43 583 674 200 283 446
2025/20269.016 504 554 550 597 680 1.909 1.066 1.205 1.265 371 156 159
2026/2027645 151 462 32 0 0 0 0 0 0 0 0 0
Totale 19.646